EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed Conditions

Hegui Yan, Ming Zhou, Zhixiang Pan, Yu Peng, Jie Wang, Xiuwen Li, Yafang Xie, Qianying Liu, Cuiping Huang, Qiuhong Wang, Guan Liu

Drugs in R&D · 2026-03 · 26 (1) · 71-81

DOI: 10.1007/s40268-026-00541-0 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drugs in R&D, online erschienen am 18.03.2026. Verfasst von Hegui Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Phase I Clinical Research Center, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, China. Hauptthemen laut MEDLINE: Nootropic Agents, Piracetam. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nootropic AgentsPiracetamAdultFemaleHumansMaleYoung AdultAdministration, OralArea Under CurveChromatography, High Pressure LiquidCross-Over StudiesFastingHealthy VolunteersTabletsTandem Mass SpectrometryTherapeutic EquivalencyDrugs, GenericEast Asian People

Substanzen

Nootropic AgentsPiracetamTabletsDrugs, Generic

Autor:innen und Institutionen

  • Phase I Clinical Research Center, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, China.
  • Clinical Research Department, China Resources Double-Crane Limin Pharmaceutical Co., Ltd. (Jinan, China), Jinan, China.
  • Phase I Clinical Research Center, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, China. liuguantbdoctor@hotmail.com.

Zitieren

APA

Yan, H., Zhou, M., Pan, Z., Peng, Y., Wang, J., Li, X., Xie, Y., Liu, Q., Huang, C., Wang, Q., & Liu, G. (2026). Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed Conditions. Drugs in R&D, 26(1), 71-81. https://doi.org/10.1007/s40268-026-00541-0

Vancouver

Yan H, Zhou M, Pan Z, Peng Y, Wang J, Li X, et al. Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed Conditions. Drugs in R&D. 2026;26(1):71-81. doi:10.1007/s40268-026-00541-0

BibTeX
@article{Yan2026,
  author = {Yan, Hegui and Zhou, Ming and Pan, Zhixiang and Peng, Yu and Wang, Jie and Li, Xiuwen and Xie, Yafang and Liu, Qianying and Huang, Cuiping and Wang, Qiuhong and Liu, Guan},
  title = {Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed Conditions},
  journal = {Drugs in R&D},
  year = {2026},
  volume = {26},
  number = {1},
  pages = {71--81},
  doi = {10.1007/s40268-026-00541-0}
}
Kostenlos starten →